HRTX - Koefisien bali modal nimbang wutah Heron Therapeutics Inc

Simbol lan logo merek Heron Therapeutics (HRTX)

Heron Therapeutics management is effectively commercializing analgesic innovations while striving for break-even. The company's valuation-to-growth ratio clearly confirms this trend, with the current value standing at 0.00. Fundamentals are supported by a steady cash flow from hospital postoperative pain management protocols and resilient B2B retention within the oncology ecosystem, driven by expanding FDA approvals.

HRTX Rasio rega marang bathi tumrap wutah Heron Therapeutics Inc (04.07.2022 - 16.11.2026)

Rincian metrik lan analitis perusahaan Heron Therapeutics (HRTX)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:Heron Therapeutics HRTX
Produk asli Heron Therapeutics Inc

The stability of Heron Therapeutics (HRTX) relies on a highly skilled staff of oncology researchers whose competencies translate directly into net profit growth rates. The PEG ratio, equal to 0.00, correlates market capitalization with revenue dynamics, where a value below one signals an undervalued asset, as clearly confirmed by the historical PEG ratio trend.

Pesaing Heron Therapeutics

Rasio rega marang bathi tumrap wutah INCY (Incyte Corporation)|Rasio rega marang bathi tumrap wutah Hutchison MediPharma HCM|Koefisien bali modal nimbang wutah NUVB|DAWN - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Monopar Therapeutics Inc|Inhibrx Biosciences (INBX) - Rasio rega marang bathi tumrap wutah|Rasio P/E diaturake wutah IMAB|FENC (fennecpharma.com) - Pangali PEG|Pangali rega marang bathi tumrap wutah nuvectis.com (NVCT)|Rasio rega marang bathi tumrap wutah Coherus Biosciences (CHRS)|CRBP - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Cardiff Oncology Corp CRDF|BeyondSpring Inc - Rasio rega marang bathi tumrap wutah|BCAB - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Lixte Biotechnology|CTXR: Pangali PEG|Rasio rega marang wutah bathi resik Cellectar CLRB|Pangali rega marang bathi tumrap wutah BLRX|Rega marang bathi kanthi panyesuaian wutah Can-Fite BioPharma CANF|Pangali rega marang bathi tumrap wutah APRE (Aprea Therapeutics Inc.)|KZIA (Kazia) - Koefisien bali modal nimbang wutah|Silexion Therapeutics - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang wutah bathi NCNA (NuCana Corp)|Chimerix, Inc - Pangali PEG|Koefisien bali modal nimbang wutah CYCC (Cyclacel Pharmaceuticals Inc.)|GTHX: Pangali PEG|Rega marang bathi kanthi panyesuaian wutah kronosbio.com (KRON)|Rasio rega marang bathi tumrap wutah Kintara Therapeutics, Inc.|ONCT: Koefisien bali modal nimbang wutah|Pangali PEG PRTG